Viridian Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Viridian Therapeutics's estimated annual revenue is currently $35.2M per year.
- Viridian Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Viridian Therapeutics has 227 Employees.
- Viridian Therapeutics grew their employee count by 51% last year.
Viridian Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | Sr. VP, Head Research | Reveal Email/Phone |
4 | Head Forecasting and Market Insights | Reveal Email/Phone |
5 | Senior Director, Drug Development | Reveal Email/Phone |
6 | Senior Director, Business Development & Strategic Alliances | Reveal Email/Phone |
7 | Senior Director, QC | Reveal Email/Phone |
8 | Associate Director Quality Control | Reveal Email/Phone |
9 | Associate Director | Reveal Email/Phone |
10 | Director, Medical Device Quality | Reveal Email/Phone |
Viridian Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 35 | 483% | $25M | N/A |
#2 | $2M | 13 | 18% | N/A | N/A |
#3 | $3.4M | 22 | 10% | N/A | N/A |
#4 | $68M | 439 | -3% | N/A | N/A |
#5 | $2M | 13 | 30% | N/A | N/A |
#6 | $4M | 26 | 8% | N/A | N/A |
#7 | $2.7M | 35 | -10% | $23.2M | N/A |
#8 | $5.3M | 34 | 70% | N/A | N/A |
#9 | $1.7M | 11 | -8% | N/A | N/A |
#10 | $3.1M | 20 | -17% | N/A | N/A |
What Is Viridian Therapeutics?
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today's therapies. Viridian's most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colo., with research and development operations in Waltham, Mass.
keywords:N/A
N/A
Total Funding
227
Number of Employees
$35.2M
Revenue (est)
51%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Viridian Therapeutics News
This table compares Sera Prognostics and Viridian Therapeutics' revenue, earnings per share and valuation. Gross Revenue, Price/Sales Ratio, Net...
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Average Recommendation of Buy by Analysts. Posted by admin on Apr 12th, 2022.
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by...
Other Companies in Boulder
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $67.7M | 228 | 16% | N/A |
#2 | $36.7M | 230 | -6% | N/A |
#3 | $53.6M | 232 | -21% | N/A |
#4 | $35.1M | 233 | 15% | $58.1M |
#5 | $70.7M | 238 | 16% | N/A |